Profil
Alex Weymouth-Wilson is currently the Chief Scientific Officer at New Zealand Pharmaceuticals Ltd. He previously worked as a Principal at PMC Isochem SAS and CMS Alphatech Ltd. Dr. Weymouth-Wilson received his undergraduate and graduate degrees from The University of Reading and his doctorate in 1993 from the same institution.
Postes actifs de Alex Weymouth-Wilson
| Sociétés | Poste | Début |
|---|---|---|
New Zealand Pharmaceuticals Ltd.
New Zealand Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical intermediates and diagnostic products | Directeur Technique/Scientifique/R&D | 01/01/2011 |
Anciens postes connus de Alex Weymouth-Wilson
| Sociétés | Poste | Fin |
|---|---|---|
CMS Alphatech Ltd. | Corporate Officer/Principal | - |
PMC Isochem SAS
PMC Isochem SAS Chemicals: SpecialtyProcess Industries Operates as contract manufacturer and supplier if fine chemicals and active pharmaceutical ingredients | Corporate Officer/Principal | - |
Formation de Alex Weymouth-Wilson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
PMC Isochem SAS
PMC Isochem SAS Chemicals: SpecialtyProcess Industries Operates as contract manufacturer and supplier if fine chemicals and active pharmaceutical ingredients | Process Industries |
The University of Reading
The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Zealand Pharmaceuticals Ltd.
New Zealand Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical intermediates and diagnostic products | Health Technology |
CMS Alphatech Ltd. |
















